TSE:ATA
19.87
0.19
(0.97%)
ATS Automation Tooling Systems is a Cambridge, Ontario based Canadian company which designs and builds factory automation solutions.
More at Wikipedia
Analysis and Opinions about ATA-T
Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
January 27, 2020
(A Top Pick Feb 05/19, Up 28%) They are automating their factories more. It has grown pretty aggressively in the health care sector. That business is not dependent on the economy. It is trading at a discount to some of its peers.
Show full opinionHide full opinion
(A Top Pick Feb 05/19, Up 28%) They are automating their factories more. It has grown pretty aggressively in the health care sector. That business is not dependent on the economy. It is trading at a discount to some of its peers.
PAST TOP PICK
PAST TOP PICK
October 15, 2019
(A Top Pick Feb 27/19, Down 6%) They're hurt by weakening European growth. He's not super-worried though, but has trimmed his position. He's bullish about the automation sector in general, so he's staying in ATS. Automation will be key in the future. Expect a few bumpy quarters.
Show full opinionHide full opinion(A Top Pick Feb 27/19, Down 6%) They're hurt by weakening European growth. He's not super-worried though, but has trimmed his position. He's bullish about the automation sector in general, so he's staying in ATS. Automation will be key in the future. Expect a few bumpy quarters.
PAST TOP PICK
PAST TOP PICK
August 1, 2019
(A Top Pick Jul 24/18, Up 14%) They make automation processes to assist companies improve their production efficiency. Earnings continue to show good growth. Sales up 17%. PE of 20 times. ROE is reasonable. He no longer owns the stock.
Show full opinionHide full opinion(A Top Pick Jul 24/18, Up 14%) They make automation processes to assist companies improve their production efficiency. Earnings continue to show good growth. Sales up 17%. PE of 20 times. ROE is reasonable. He no longer owns the stock.
HOLD
HOLD
July 22, 2019
It's historically been expensive, but not now. They're executing well and just bought a company in Italy. They have robust back orders. Hold, if you own it, but keep an eye on their next report. They bounced back with a good quarter recently after a new CEO came onboard. Has a good shareholder base, which will limit knee-jerk stock reactions.
Show full opinionHide full opinionIt's historically been expensive, but not now. They're executing well and just bought a company in Italy. They have robust back orders. Hold, if you own it, but keep an eye on their next report. They bounced back with a good quarter recently after a new CEO came onboard. Has a good shareholder base, which will limit knee-jerk stock reactions.
PAST TOP PICK
PAST TOP PICK
April 12, 2019
(A Top Pick Jul 24/18, Up 8%) He continues to rank it highly although he no longer owns it.
Show full opinionHide full opinion(A Top Pick Jul 24/18, Up 8%) He continues to rank it highly although he no longer owns it.
SELL STRENGTH
SELL STRENGTH
March 11, 2019
He'd sell around $20 if it breaks through which looks quite possible. In tech analysis, a stock has to break through a new level.
Show full opinionHide full opinionHe'd sell around $20 if it breaks through which looks quite possible. In tech analysis, a stock has to break through a new level.
TOP PICK
TOP PICK
February 27, 2019
They make automation systems and robotics for manufacturing in autos and biopharma. ATS need to create a recurring revenue stream from that. So, this new CEO is creating that and this should raise earnings. (Analysts’ price target is $23.25)
Show full opinionHide full opinionThey make automation systems and robotics for manufacturing in autos and biopharma. ATS need to create a recurring revenue stream from that. So, this new CEO is creating that and this should raise earnings. (Analysts’ price target is $23.25)
COMMENT
COMMENT
February 8, 2019
It gapped higher at $17 following earnings, but hit its 200-day moving average and now going lower. Be cautious here long-term. Feb-July is its seasonality.
Show full opinionHide full opinionIt gapped higher at $17 following earnings, but hit its 200-day moving average and now going lower. Be cautious here long-term. Feb-July is its seasonality.
TOP PICK
TOP PICK
February 5, 2019
Poor Q3 pressured the stock, but sees secular growth in warehouse automation, healthcare equipment and e-cars (to do the automation in those factories). A healthy balance sheet. They just announced an acqusition; he expects more M&A to drive growth. Trading at a low multiple vs. history and peers. Good value here. (Analysts’ price target is $23.25)
Show full opinionHide full opinionPoor Q3 pressured the stock, but sees secular growth in warehouse automation, healthcare equipment and e-cars (to do the automation in those factories). A healthy balance sheet. They just announced an acqusition; he expects more M&A to drive growth. Trading at a low multiple vs. history and peers. Good value here. (Analysts’ price target is $23.25)
BUY
BUY
February 5, 2019
Long history in Canada. Very sensitive to the economic cycle. Now that recession has been put off, it's at a better entry level. Has been a very expensive stock. New management made complementary, but expensive, acquisitions. Given the pullback, he'd be inclined to buy. Well run, and deserves its high multiple. In choppy markets, it will be one of the first to sell off.
Show full opinionHide full opinionLong history in Canada. Very sensitive to the economic cycle. Now that recession has been put off, it's at a better entry level. Has been a very expensive stock. New management made complementary, but expensive, acquisitions. Given the pullback, he'd be inclined to buy. Well run, and deserves its high multiple. In choppy markets, it will be one of the first to sell off.
WEAK BUY
WEAK BUY
November 27, 2018
They got smacked when they missed their quarter. He's long ATS. It does well counter-cyclically, which means as we head towards a rougher economy, this tends to perform better. He believes management will turn this around. This could be a defensive name as he heads towards a rocky economy.
Show full opinionHide full opinionThey got smacked when they missed their quarter. He's long ATS. It does well counter-cyclically, which means as we head towards a rougher economy, this tends to perform better. He believes management will turn this around. This could be a defensive name as he heads towards a rocky economy.
BUY
BUY
November 15, 2018
Well-valued after coming off a sharp sell-off. One segment they deal in is a strong growth segment. It's a good time to enter this.
Show full opinionHide full opinionWell-valued after coming off a sharp sell-off. One segment they deal in is a strong growth segment. It's a good time to enter this.
BUY
BUY
September 13, 2018
They do tooling for factories. Manufacturing is moving to e-vehicles and more automation in factories. ATS can do this. Backlog is growing and just bought a company today. High valuation. Sound strategy. He has a 5-year timeline for ATS. Things are playing out well for them. Likes it.
They do tooling for factories. Manufacturing is moving to e-vehicles and more automation in factories. ATS can do this. Backlog is growing and just bought a company today. High valuation. Sound strategy. He has a 5-year timeline for ATS. Things are playing out well for them. Likes it.
BUY
BUY
August 28, 2018
This is one of his biggest positions. They report growth quarter after quarter. They were a challenged company but they changed management, changed focus to health care sector and cleaned up the balance sheet. They have no net debt. The stock has had a big run-up but the fundamentals have been going up at least as fast. It trades at a discount to US peers even though it has a much better balance sheet. It trades at about 12x EBITDA and peers trade in the mid-teens.
This is one of his biggest positions. They report growth quarter after quarter. They were a challenged company but they changed management, changed focus to health care sector and cleaned up the balance sheet. They have no net debt. The stock has had a big run-up but the fundamentals have been going up at least as fast. It trades at a discount to US peers even though it has a much better balance sheet. It trades at about 12x EBITDA and peers trade in the mid-teens.
TOP PICK
TOP PICK
July 24, 2018
They design and build turnkey manufacturing and test systems. Doesn’t pay a dividend, but he thinks it is coming out of a long sleep with great opportunities as many companies bring manufacturing back to North America. They had a big earnings surprise this quarter and analysts’ forecasts have been revised significantly upward. Looking at the technical pattern, he thinks there is a possible 50% upside. (Analysts’ price target is $22.40)
They design and build turnkey manufacturing and test systems. Doesn’t pay a dividend, but he thinks it is coming out of a long sleep with great opportunities as many companies bring manufacturing back to North America. They had a big earnings surprise this quarter and analysts’ forecasts have been revised significantly upward. Looking at the technical pattern, he thinks there is a possible 50% upside. (Analysts’ price target is $22.40)
